Evolution of IL-6 as possible marker of viral control in Covid-19

被引：0
|
作者：
De Diego Ramos, C. [1 ]
Lopez, L. [1 ]
Torralba, L. [1 ]
Lasierra, A. [2 ]
Lahoz, R.
Abadia, C. [1 ]
Ruiz De Gopegui, P. [1 ]
Cebollada, A. [3 ]
Godino, J. [3 ]
Jimeno, B. [3 ]
Bello, S. [1 ]
机构：
[1] Hosp Univ Miguel Servet, Zaragoza, Spain
[2] Hosp San Jorge, Huesca, Spain
[3] Inst Aragones Ciencias Salud, Zaragoza, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.3202
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3202
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The role of vitamin D receptor and IL-6 in COVID-19
    Azmi, Ali
    Rismani, Maziyar
    Pourmontaseri, Hossein
    Mirzaii, Ebrahim
    Niknia, Sedigheh
    Miladpour, Behnoosh
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2023, 11 (07):
  • [22] Is IL-6 a key cytokine target for therapy in COVID-19?
    Simon A. Jones
    Christopher A. Hunter
    Nature Reviews Immunology, 2021, 21 : 337 - 339
  • [23] Is IL-6 a key cytokine target for therapy in COVID-19?
    Jones, Simon A.
    Hunter, Christopher A.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (06) : 337 - 339
  • [24] Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6
    Quartuccio, Luca
    Sonaglia, Arianna
    Pecori, Davide
    Peghin, Maddalena
    Fabris, Martina
    Tascini, Carlo
    De Vita, Salvatore
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2852 - 2856
  • [25] Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19
    Chulanov, Vladimir P.
    Bakirov, Bulat A.
    Vezikova, Natalia N.
    Gorodin, Vladimir N.
    V. Zhuravleva, Marina
    Zagrebneva, Alena I.
    Ivanov, Igor G.
    V. Lomakin, Nikita
    V. Lukina, Galina
    Moysova, Diana L.
    Mutovina, Zinaida Iu.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (08) : 1028 - 1035
  • [26] IL-6 blockade for COVID-19: a global scientific call to arms
    Murthy, Srinivas
    Lee, Todd C.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (05): : 438 - 440
  • [27] Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
    Flisiak, Robert
    Jaroszewicz, Jerzy
    Rogalska, Magdalena
    Lapinski, Tadeusz
    Berkan-Kawinska, Aleksandra
    Bolewska, Beata
    Tudrujek-Zdunek, Magdalena
    Kozielewicz, Dorota
    Rorat, Marta
    Leszczynski, Piotr
    Klos, Krzysztof
    Kowalska, Justyna
    Pabjan, Pawel
    Piekarska, Anna
    Mozer-Lisewska, Iwona
    Tomasiewicz, Krzysztof
    Pawlowska, Malgorzata
    Simon, Krzysztof
    Polanska, Joanna
    Zarebska-Michaluk, Dorota
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [28] Clinical significance of IL-6 in severe and critical COVID-19 patients
    Kawamata, Takaya
    Tanino, Yoshinori
    Wang, Xintao
    Nikaido, Takefumi
    Sato, Yuki
    Togawa, Ryuichi
    Watanabe, Natsumi
    Saito, Koshi
    Kazama, Kentaro
    Harigane, Rina
    Yamada, Ryuki
    Tomita, Hikaru
    Rikimaru, Mami
    Morimoto, Julia
    Minemura, Hiroyuki
    Saito, Junpei
    Kanazawa, Kenya
    Shibata, Yoko
    RESPIROLOGY, 2023, 28 : 136 - 136
  • [29] IL-6 Receptor Inhibitors in COVID-19: Efficacy on the Test Bench
    Wagner, Annkatrin
    TRANSFUSIONSMEDIZIN, 2021, 11 (03) : 151 - 151
  • [30] Relationship between IL-6 and COVID-19: to be considered during treatment
    Vatansever, Hafize Seda
    Becer, Eda
    FUTURE VIROLOGY, 2020, 15 (12) : 817 - 822
12345